Solitron Devices, Inc. Announces Fiscal 2027 Second Quarter Results

Solitron Devices posts strong sales, bookings, and profit growth with record backlog.

What the company is saying

Solitron Devices reports a 42% year-over-year increase in net sales to $5.66 million for the fiscal 2027 second quarter, highlighting robust demand and operational momentum. Management emphasizes a 48% jump in net bookings to $6.42 million and a 29% rise in backlog to $24.11 million, framing these as evidence of sustained customer demand and future revenue visibility. The company points to a swing from a net loss of ($0.23) million last year to net income of $1.30 million, or $0.60 per share, this quarter, attributing sequential revenue growth to a strong backlog. Solitron discloses that net income was reduced by $200,000 in professional fees for an investment banker engaged to explore strategic alternatives, and notes $52,000 in intangible amortization in SG&A. The release states that no cash income taxes were paid due to deferred tax assets from prior losses. Management expresses optimism about potential multi-year orders for AMRAAM and Standard Missile programs, referencing recently announced multi-year agreements by RTX and the Pentagon that require Congressional funding, and expects the next AMRAAM order in the fiscal fourth quarter. The tone is confident, with a focus on realised operational improvements and cautious optimism about future defense contract opportunities.

What the data suggests

The disclosed figures show a marked improvement in financial performance. Net sales rose 42% year-over-year to $5.66 million for the quarter, and net bookings increased 48% to $6.42 million, indicating strong demand. Backlog reached $24.11 million, up 29% from the prior year and up sequentially from $23.34 million in the previous quarter, providing visibility into future revenue. Net income improved to $1.30 million from a ($0.23) million loss a year ago, with EPS at $0.60 versus ($0.11) prior. Gross profit for the quarter was $2,748,000 on sales of $5,657,000, with operating income at $1,715,000. For the six months ended August 31, 2026, net sales were $11,093,000 and net income was $2,288,000, both up sharply year-over-year. The company incurred $200,000 in professional fees for strategic review, which reduced net income, and $52,000 in intangible amortization. No cash taxes were paid due to deferred tax assets. While management is optimistic about future multi-year defense orders, no new contracts or order values are confirmed, and these remain contingent on Congressional funding. The data quality is high for realised results, but forward pipeline visibility depends on external government decisions.

Analysis

The announcement's tone is positive, but this is proportionate to the company's strong, realised financial performance. The majority of key claims are supported by detailed, audited or management-reviewed financial data: net sales, bookings, backlog, net income, and per-share results all show significant year-over-year and sequential improvement. Profitability metrics (net income, operating income, gross profit) are disclosed alongside revenue, satisfying the completeness rule for a strong_positive signal. Forward-looking statements regarding potential multi-year defense orders are clearly separated from realised results and are not presented as guaranteed outcomes. There is no evidence of narrative inflation or overstatement; the language around future opportunities is appropriately cautious and does not overshadow the substantial realised progress. No large capital outlay is disclosed without immediate earnings impact, and the only capital signal (investment banker fees) is modest and fully expensed in the quarter.

Risk flags

• ●Future growth is partially dependent on securing multi-year defense orders for AMRAAM and Standard Missile programs, which require Congressional funding and are not yet booked. Delays or reductions in government spending could materially impact future revenue and backlog.
• ●The company's backlog, while at record levels, is concentrated in military and aerospace markets, exposing Solitron to risks from changes in U.S. government procurement, policy shifts, or geopolitical events such as the war in Ukraine.
• ●Professional fees of $200,000 related to strategic alternatives reduced quarterly net income, and ongoing costs or outcomes from this process could affect future profitability and strategic direction.
• ●No actual income taxes were paid this quarter due to deferred tax assets, but future profitability could eventually exhaust these assets, leading to higher effective tax rates in subsequent periods.

Bottom line

Solitron Devices delivered a strong quarter, with double-digit growth in sales, bookings, and backlog, and a return to profitability. The company’s operational momentum is clear, and the record backlog provides near-term revenue visibility. However, the next phase of growth hinges on securing large, multi-year defense orders that remain subject to Congressional funding and are not yet reflected in the numbers. The $200,000 in professional fees for strategic review signals possible corporate changes ahead, but the immediate impact was a reduction in net income. Investors should focus on whether the anticipated AMRAAM and Standard Missile orders materialize in the coming months, as these could significantly affect future results. The most important takeaway is that Solitron’s current financial trajectory is strong, but sustaining this momentum will require converting pipeline opportunities into firm contracts.

Announcement summary

(OTC:SODI) Solitron Devices, Inc. announced its fiscal 2027 second quarter results. Net sales increased 42% to approximately $5.66 million in the fiscal 2027 second quarter compared to $3.99 million in the fiscal 2026 second quarter. Net bookings rose 48% to $6.42 million in the fiscal 2027 second quarter versus $4.32 million in the prior year second quarter. The company's backlog increased 29% to $24.11 million at the end of the fiscal 2027 second quarter, up from $18.64 million at the end of the fiscal 2026 second quarter. Net income for the fiscal 2027 second quarter was $1.30 million, or $0.60 per share, compared to a net loss of ($0.23) million, or ($0.11) per share, for the fiscal 2026 second quarter. Revenue increased to $5.66 million in the fiscal 2027 second quarter from $5.44 million in the first quarter, attributed to the company’s strong backlog. Backlog also increased from $23.34 million at the end of the fiscal 2027 first quarter to $24.11 million at the end of the second quarter. The quarter’s net income was negatively impacted by $200,000 in professional fees recorded to SG&A related to the retention of an investment banker for strategic alternatives. SG&A costs for both the fiscal 2027 and 2026 second quarters included $52,000 of intangible amortization. The company reported that while income taxes are reflected in the income statement, no actual income taxes were due due to deferred tax assets from previous net operating losses. The company continues to be encouraged about the possibility of multi-year orders for components on AMRAAM and Standard Missiles 2, 3, and 6, with RTX and the Pentagon announcing multi-year agreements in October for both programs, pending Congressional funding. The company expects the next AMRAAM order to be received in the fiscal fourth quarter. For the three months ended August 31, 2026, net sales were $5,657, cost of sales $2,909, gross profit $2,748, SG&A expenses $1,033, operating income $1,715, total other income $51, net income before income tax $1,766, income tax expense $468, and net income $1,298. For the three months ended August 31, 2025, net sales were $3,986, cost of sales $3,151, gross profit $835, SG&A expenses $1,126, operating loss ($291), total other loss ($29), net loss before income tax ($320), income tax benefit $86, and net loss ($234). For the six months ended August 31, 2026, net sales were $11,093, cost of sales $5,880, gross profit $5,213, SG&A expenses $1,963, operating income $3,250, total other loss ($137), net income before income tax $3,113, income tax expense $825, and net income $2,288. For the six months ended August 31, 2025, net sales were $6,686, cost of sales $5,461, gross profit $1,225, SG&A expenses $1,894, operating loss ($669), total other loss ($108), net loss before income tax ($777), income tax benefit $207, and net loss ($570). Net income per common share for the three months ended August 31, 2026, was $0.60, and for the six months ended August 31, 2026, was $1.06. Weighted average shares outstanding for the three months ended August 31, 2026, were 2,152,703, and for the six months ended August 31, 2026, were 2,152,377. The unaudited financial information is based on management's review and available information as of the press release date. The company's independent auditors have audited results for the fiscal year ending February 28, 2026. Effective September 1, 2023, Solitron closed its acquisition of Micro Engineering Inc. (MEI).

Disagree with this article?